# MedResearch AI â€” Requirements Document

## 1. Project Overview

### Product Name
**MedResearch AI** â€” Conversational Research Assistant for Life Sciences

### Purpose
MedResearch AI is an intelligent conversational assistant designed to accelerate research workflows in healthcare and life sciences by providing instant access to synthesized information from clinical trials, research papers, and regulatory documents.

### Problem Statement
Researchers and scientists in life sciences spend significant time manually reviewing hundreds of research papers, clinical trial results, and regulatory documents. This manual process is:
- Time-consuming and inefficient
- Prone to missing critical information across multiple sources
- Difficult to synthesize and compare findings across studies
- Challenging to maintain proper citations and references

### Target Users
- **Primary**: Clinical researchers, pharmaceutical scientists, biomedical researchers
- **Secondary**: Regulatory affairs specialists, medical writers, academic researchers
- **Tertiary**: Healthcare policy analysts, grant writers

### Key Goals
1. Reduce research literature review time by 60%
2. Enable rapid comparison of clinical trial outcomes across multiple studies
3. Provide accurate, citation-backed responses to research queries
4. Generate structured research documentation ready for publication or reporting
5. Ensure compliance-aware guidance for regulatory requirements

### Success Metrics
| Metric | Target | Measurement Method |
|--------|--------|-------------------|
| Query Response Time | < 5 seconds | System performance monitoring |
| Citation Accuracy | > 95% | Manual validation sampling |
| User Satisfaction | > 4.2/5.0 | Post-interaction surveys |
| Time Saved per Research Task | > 50% | User time-tracking studies |
| Monthly Active Users | 1,000+ users | Analytics dashboard |
| Query Success Rate | > 90% | Successful query resolution tracking |

---

## 2. Functional Requirements

### FR-001: Conversational AI Chatbot Interface
**Priority**: P0 (Critical)

The system shall provide a natural language conversational interface that:
- Accepts free-form text queries in English
- Maintains conversation context across multiple turns
- Supports follow-up questions and clarifications
- Provides typing indicators and real-time response streaming
- Handles ambiguous queries with clarifying questions
- Supports multi-turn dialogues with context retention (minimum 10 exchanges)

### FR-002: Research Paper Summarization
**Priority**: P0 (Critical)

The system shall:
- Summarize research papers from PubMed, bioRxiv, and medRxiv
- Extract key information: objectives, methodology, results, conclusions
- Identify study limitations and potential biases
- Highlight statistical significance and confidence intervals
- Support summarization of papers by PMID, DOI, or title
- Generate summaries in multiple formats (brief, detailed, technical)

### FR-003: Clinical Trial Analysis
**Priority**: P0 (Critical)

The system shall:
- Retrieve and summarize clinical trials from ClinicalTrials.gov
- Extract trial phases, endpoints, participant demographics
- Summarize efficacy and safety outcomes
- Identify trial status (recruiting, completed, terminated)
- Compare primary and secondary outcome measures
- Highlight adverse events and safety signals

### FR-004: Drug Efficacy Comparison
**Priority**: P1 (High)

The system shall:
- Compare efficacy data across multiple clinical trials
- Generate side-by-side comparison tables
- Identify head-to-head trial data when available
- Highlight differences in study design, populations, and endpoints
- Calculate and present effect sizes and confidence intervals
- Provide meta-analysis summaries when applicable

### FR-005: Regulatory & Compliance Document Navigation
**Priority**: P1 (High)

The system shall:
- Answer questions about FDA, EMA, and ICH guidelines
- Retrieve relevant regulatory guidance documents
- Explain compliance requirements for specific drug classes
- Summarize regulatory approval pathways
- Provide updates on regulatory changes and new guidance
- Link to official regulatory source documents

### FR-006: Structured Research Documentation Generation
**Priority**: P1 (High)

The system shall generate:
- Literature review summaries
- Clinical trial synopsis documents
- Comparative efficacy tables
- Safety profile summaries
- Regulatory compliance checklists
- Research methodology descriptions

### FR-007: Source Citation and Reference Tracking
**Priority**: P0 (Critical)

The system shall:
- Provide inline citations for all factual claims
- Link citations to original source documents
- Generate formatted reference lists (APA, Vancouver, AMA styles)
- Track all sources used in generating responses
- Display confidence scores for each cited fact
- Enable users to verify claims against original sources

### FR-008: Query History and Session Management
**Priority**: P1 (High)

The system shall:
- Save conversation history for logged-in users
- Allow users to resume previous research sessions
- Enable search within conversation history
- Support session naming and organization
- Provide conversation bookmarking functionality
- Allow deletion of conversation history

### FR-009: Export Functionality
**Priority**: P1 (High)

The system shall support export in:
- PDF format with formatted citations
- Markdown format for documentation systems
- Plain text format
- CSV format for tabular data
- BibTeX format for reference management
- Include metadata (export date, query parameters, sources)

### FR-010: User Authentication and Workspace Management
**Priority**: P1 (High)

The system shall:
- Support secure user registration and login
- Provide OAuth integration (Google, institutional SSO)
- Enable personal workspace creation
- Support workspace sharing and collaboration (future)
- Implement role-based access control
- Provide usage analytics per user

---

## 3. Non-Functional Requirements

### NFR-001: Performance
**Priority**: P0 (Critical)

| Requirement | Target | Rationale |
|-------------|--------|-----------|
| Query Response Time | < 5 seconds (p95) | Maintain conversational flow |
| Simple Query Response | < 2 seconds (p95) | Quick factual lookups |
| Complex Analysis Response | < 10 seconds (p95) | Multi-source synthesis |
| Concurrent Users | 500+ simultaneous | Support research team usage |
| Document Processing | < 30 seconds per paper | Efficient summarization |
| API Response Time | < 1 second | Backend service performance |

### NFR-002: Scalability
**Priority**: P1 (High)

- Horizontal scaling capability for API services
- Support for 10,000+ registered users
- Handle 100,000+ queries per day
- Database partitioning for conversation history
- CDN integration for static assets
- Auto-scaling based on load patterns

### NFR-003: Security & Data Privacy
**Priority**: P0 (Critical)

- **HIPAA-Aware Design**: No storage or processing of real patient data
- **Data Encryption**: TLS 1.3 for data in transit, AES-256 for data at rest
- **Authentication**: Multi-factor authentication support
- **Authorization**: Role-based access control (RBAC)
- **Audit Logging**: Complete audit trail of all user actions
- **Session Management**: Secure session tokens with 24-hour expiration
- **Input Validation**: Sanitization of all user inputs
- **Rate Limiting**: Prevent abuse and DDoS attacks

### NFR-004: Accuracy & Hallucination Prevention
**Priority**: P0 (Critical)

- **Grounded Responses**: All responses must cite source documents
- **Confidence Scoring**: Display confidence levels for each claim
- **Uncertainty Handling**: Explicitly state when information is unavailable
- **Fact Verification**: Cross-reference claims across multiple sources
- **Hallucination Detection**: Implement guardrails to detect unsupported claims
- **Human-in-the-Loop**: Flag low-confidence responses for review
- **Source Quality**: Prioritize peer-reviewed and official sources

### NFR-005: Accessibility
**Priority**: P1 (High)

- **WCAG 2.1 Level AA Compliance**: Meet accessibility standards
- **Keyboard Navigation**: Full functionality without mouse
- **Screen Reader Support**: ARIA labels and semantic HTML
- **Color Contrast**: Minimum 4.5:1 contrast ratio
- **Text Resizing**: Support up to 200% zoom without loss of functionality
- **Alternative Text**: Descriptive alt text for all images and charts

### NFR-006: Availability & Reliability
**Priority**: P1 (High)

| Metric | Target | Measurement |
|--------|--------|-------------|
| Uptime SLA | 99.5% | Monthly uptime monitoring |
| Mean Time to Recovery (MTTR) | < 1 hour | Incident response time |
| Error Rate | < 0.5% | Failed requests / total requests |
| Data Backup Frequency | Daily | Automated backup verification |
| Disaster Recovery RTO | < 4 hours | Recovery time objective |
| Disaster Recovery RPO | < 1 hour | Recovery point objective |

### NFR-007: Maintainability
**Priority**: P2 (Medium)

- Modular architecture with clear separation of concerns
- Comprehensive API documentation (OpenAPI/Swagger)
- Code coverage > 80% for critical paths
- Automated deployment pipelines (CI/CD)
- Monitoring and alerting infrastructure
- Detailed logging for debugging and troubleshooting

### NFR-008: Usability
**Priority**: P1 (High)

- Intuitive interface requiring < 5 minutes onboarding
- Contextual help and tooltips
- Example queries and use case templates
- Progressive disclosure of advanced features
- Mobile-responsive design
- Support for common research workflows

---

## 4. Data Requirements

### DR-001: Data Source Policy
**Priority**: P0 (Critical)

**Allowed Data Sources**:
- âœ… PubMed / PubMed Central (PMC)
- âœ… ClinicalTrials.gov
- âœ… FDA Drug Database (Drugs@FDA)
- âœ… FDA Guidance Documents
- âœ… EMA Public Assessment Reports
- âœ… WHO International Clinical Trials Registry
- âœ… bioRxiv / medRxiv preprint servers
- âœ… NIH Reporter (grant data)
- âœ… Synthetic datasets for testing

**Prohibited Data Sources**:
- âŒ Electronic Health Records (EHR)
- âŒ Real patient data or Protected Health Information (PHI)
- âŒ Proprietary clinical trial data
- âŒ Non-public pharmaceutical company data
- âŒ Personally Identifiable Information (PII)

### DR-002: Data Ingestion Strategy
**Priority**: P0 (Critical)

The system shall implement:
- **Automated Data Pipelines**: Daily synchronization with public APIs
- **Incremental Updates**: Only fetch new or updated records
- **Data Validation**: Schema validation and quality checks
- **Metadata Extraction**: Authors, dates, identifiers, keywords
- **Version Control**: Track data source versions and update timestamps
- **Error Handling**: Retry logic and failure notifications

### DR-003: Data Indexing and Retrieval (RAG Architecture)
**Priority**: P0 (Critical)

**Retrieval-Augmented Generation (RAG) Implementation**:

1. **Document Processing**:
   - Text extraction from PDFs and structured data
   - Chunking strategy: 512-token chunks with 50-token overlap
   - Metadata preservation (source, date, authors, DOI/PMID)

2. **Embedding Generation**:
   - Use domain-specific biomedical embeddings (e.g., BioBERT, PubMedBERT)
   - Generate embeddings for all document chunks
   - Store embeddings in vector database (Pinecone, Weaviate, or Qdrant)

3. **Retrieval Strategy**:
   - Semantic search using cosine similarity
   - Hybrid search combining semantic and keyword matching
   - Re-ranking retrieved documents by relevance
   - Retrieve top-k documents (k=5-10) per query

4. **Context Augmentation**:
   - Inject retrieved documents into LLM context
   - Include source metadata for citation generation
   - Implement context window management (max 8K tokens)

### DR-004: Data Quality and Validation
**Priority**: P1 (High)

- **Completeness Checks**: Validate required fields are present
- **Consistency Validation**: Cross-reference data across sources
- **Timeliness**: Flag outdated information (> 5 years old)
- **Source Credibility**: Prioritize peer-reviewed sources
- **Duplicate Detection**: Identify and merge duplicate records
- **Data Lineage**: Track data provenance and transformations

### DR-005: Disclaimer and Limitations
**Priority**: P0 (Critical)

The system shall display prominent disclaimers:

> **Important Disclaimer**
> 
> MedResearch AI is a research tool that uses publicly available data sources. This system:
> - Is NOT a substitute for professional medical, clinical, or regulatory advice
> - Does not provide medical diagnoses or treatment recommendations
> - May contain errors, omissions, or outdated information
> - Should not be used for patient care decisions
> - Requires verification of all information against original sources
> - Is intended for research and educational purposes only
> 
> Always consult qualified healthcare professionals and refer to official regulatory guidance for clinical and compliance decisions.

---

## 5. User Stories

### US-001: Summarizing a Clinical Trial
**As a** clinical researcher  
**I want to** quickly summarize a clinical trial by its NCT number  
**So that** I can understand the trial design, outcomes, and safety profile without reading the full protocol

**Acceptance Criteria**:
- Given I provide an NCT number (e.g., NCT04280705)
- When I ask "Summarize this clinical trial"
- Then the system returns: trial phase, intervention, primary endpoints, enrollment, status, key results, and adverse events
- And provides a link to the original ClinicalTrials.gov entry
- And completes the response in < 5 seconds

### US-002: Comparing Two Drugs Across Studies
**As a** pharmaceutical scientist  
**I want to** compare the efficacy of Drug A vs Drug B across multiple clinical trials  
**So that** I can evaluate relative effectiveness for a specific indication

**Acceptance Criteria**:
- Given I ask "Compare the efficacy of pembrolizumab vs nivolumab in non-small cell lung cancer"
- When the system processes my query
- Then it retrieves relevant clinical trials for both drugs
- And generates a comparison table showing: response rates, progression-free survival, overall survival, and adverse events
- And cites all source trials with NCT numbers and publications
- And highlights any head-to-head trial data if available

### US-003: Navigating FDA Compliance Requirements
**As a** regulatory affairs specialist  
**I want to** understand FDA requirements for accelerated approval pathways  
**So that** I can determine if our drug candidate qualifies

**Acceptance Criteria**:
- Given I ask "What are the FDA requirements for accelerated approval?"
- When the system processes my query
- Then it summarizes the key criteria from FDA guidance documents
- And provides examples of drugs approved via this pathway
- And links to official FDA guidance documents
- And explains the post-approval requirements

### US-004: Generating a Research Summary Report
**As a** medical writer  
**I want to** generate a structured literature review on a specific topic  
**So that** I can use it as a foundation for a manuscript or report

**Acceptance Criteria**:
- Given I ask "Generate a literature review on CAR-T therapy for B-cell lymphoma"
- When the system processes my query
- Then it creates a structured document with: introduction, methodology overview, key findings, safety considerations, and conclusions
- And includes a formatted reference list with 15-30 citations
- And allows me to export as PDF or Markdown
- And completes generation in < 15 seconds

### US-005: Citing Sources for a Research Finding
**As a** academic researcher  
**I want to** verify the sources behind an AI-generated claim  
**So that** I can ensure accuracy before including it in my publication

**Acceptance Criteria**:
- Given the AI makes a factual claim in its response
- When I view the response
- Then each claim has an inline citation number [1], [2], etc.
- And I can click the citation to view the source document
- And the reference list includes: authors, title, journal, year, DOI/PMID
- And I can access the original source document

### US-006: Exporting a Conversation Summary
**As a** research team lead  
**I want to** export my conversation with the AI as a PDF report  
**So that** I can share findings with my team and maintain records

**Acceptance Criteria**:
- Given I have completed a research conversation
- When I click "Export Conversation"
- Then I can choose format: PDF, Markdown, or Plain Text
- And the export includes: all queries and responses, citations, timestamp, and disclaimer
- And the PDF is formatted professionally with proper headers and page numbers
- And the export completes in < 10 seconds

### US-007: Tracking Drug Safety Signals
**As a** pharmacovigilance researcher  
**I want to** identify common adverse events across multiple trials of a specific drug  
**So that** I can assess the safety profile comprehensively

**Acceptance Criteria**:
- Given I ask "What are the most common adverse events for trastuzumab?"
- When the system processes my query
- Then it aggregates adverse event data from multiple clinical trials
- And presents a ranked list of adverse events with frequencies
- And distinguishes between serious and non-serious events
- And cites all source trials

### US-008: Understanding Study Methodology
**As a** biostatistician  
**I want to** understand the statistical methods used in a clinical trial  
**So that** I can evaluate the validity of the results

**Acceptance Criteria**:
- Given I ask about statistical methods for a specific trial
- When the system processes my query
- Then it extracts: sample size calculation, randomization method, statistical tests used, and handling of missing data
- And explains the appropriateness of the methods
- And identifies any methodological limitations

---

## 6. Constraints & Limitations

### Technical Constraints
- **Data Sources**: Limited to publicly available data only; no proprietary or patient-level data
- **Language Support**: English only in v1 (future: multilingual support)
- **Query Complexity**: Maximum 500 words per query
- **Context Window**: Limited to 8,000 tokens for LLM processing
- **Rate Limiting**: 100 queries per user per hour to prevent abuse
- **File Upload**: Not supported in v1 (future: PDF upload for analysis)

### Regulatory Constraints
- **No Medical Advice**: System cannot provide medical diagnoses or treatment recommendations
- **No Patient Data**: Strict prohibition on processing PHI or PII
- **Disclaimer Requirements**: Must display disclaimers on every response
- **Audit Trail**: Must maintain logs for compliance verification
- **Geographic Restrictions**: Initially US-focused regulatory guidance (FDA); EMA support in future

### AI Model Constraints
- **Hallucination Risk**: AI may generate plausible but incorrect information
- **Confidence Limitations**: Cannot guarantee 100% accuracy
- **Bias**: May reflect biases present in training data and source literature
- **Temporal Limitations**: Knowledge cutoff based on data ingestion date
- **Citation Accuracy**: Citations must be verified against original sources
- **Interpretation Limits**: Cannot replace expert human judgment

### User Experience Constraints
- **Response Time**: Complex queries may take 5-10 seconds
- **Source Availability**: Some papers may be behind paywalls (provide DOI only)
- **Data Freshness**: Data updated daily, not real-time
- **Query Ambiguity**: May require clarifying questions for vague queries
- **Export Limits**: Maximum 50 pages per PDF export

### Legal & Ethical Constraints
- **Terms of Service**: Users must accept terms acknowledging limitations
- **Liability**: Clear disclaimers limiting liability for AI-generated content
- **Copyright**: Respect copyright of source materials (fair use for summarization)
- **Attribution**: Proper citation of all source materials
- **Transparency**: Clear communication about AI capabilities and limitations

---

## 7. Acceptance Criteria

### AC-001: Research Paper Summarization
**Feature**: FR-002

**Given** a user provides a valid PMID (e.g., PMID: 33301246)  
**When** the user requests a summary  
**Then** the system shall:
- Retrieve the paper from PubMed within 2 seconds
- Generate a summary including: objective, methods, results, conclusions
- Include inline citations with PMID link
- Display confidence score â‰¥ 0.85
- Complete response in < 5 seconds

**And** the summary shall be factually accurate when validated against the original paper

### AC-002: Clinical Trial Comparison
**Feature**: FR-004

**Given** a user requests comparison of two drugs  
**When** the system identifies relevant clinical trials  
**Then** the system shall:
- Retrieve at least 3 trials per drug (if available)
- Generate a comparison table with: efficacy metrics, safety data, study populations
- Highlight statistically significant differences
- Cite all source trials with NCT numbers
- Flag any limitations in comparability (different endpoints, populations)

**And** the comparison shall be presented in a structured table format

### AC-003: Citation Accuracy
**Feature**: FR-007

**Given** the AI generates a response with factual claims  
**When** the response is displayed to the user  
**Then** the system shall:
- Provide inline citations for every factual claim
- Include clickable links to source documents
- Generate a formatted reference list at the end
- Achieve â‰¥ 95% citation accuracy when manually validated
- Display confidence scores for each cited fact

**And** users shall be able to verify claims against original sources

### AC-004: Export Functionality
**Feature**: FR-009

**Given** a user completes a research conversation  
**When** the user selects "Export as PDF"  
**Then** the system shall:
- Generate a PDF within 10 seconds
- Include all queries, responses, and citations
- Format with professional styling (headers, page numbers, table of contents)
- Include metadata (export date, user, session ID)
- Include disclaimer on first page
- Limit file size to < 10 MB

**And** the PDF shall be downloadable and readable in standard PDF viewers

### AC-005: Response Time Performance
**Feature**: NFR-001

**Given** the system is under normal load (< 100 concurrent users)  
**When** a user submits a query  
**Then** the system shall:
- Acknowledge receipt within 500ms
- Display typing indicator immediately
- Stream response tokens in real-time
- Complete simple queries in < 2 seconds (p95)
- Complete complex queries in < 10 seconds (p95)

**And** response times shall be monitored and logged for SLA compliance

### AC-006: Authentication and Security
**Feature**: FR-010, NFR-003

**Given** a new user visits the application  
**When** the user attempts to register  
**Then** the system shall:
- Require email verification
- Enforce strong password policy (min 12 characters, mixed case, numbers, symbols)
- Support OAuth login (Google)
- Create secure session with 24-hour expiration
- Encrypt all data in transit (TLS 1.3)
- Log authentication events for audit

**And** failed login attempts shall be rate-limited (max 5 attempts per 15 minutes)

### AC-007: Disclaimer Display
**Feature**: DR-005

**Given** a user accesses the application for the first time  
**When** the user logs in  
**Then** the system shall:
- Display a prominent disclaimer modal
- Require explicit acceptance before proceeding
- Show disclaimer in footer of every page
- Include disclaimer in all exported documents
- Log disclaimer acceptance with timestamp

**And** the disclaimer shall be clearly visible and not dismissible permanently

### AC-008: Error Handling and Graceful Degradation
**Feature**: NFR-006

**Given** the system encounters an error (API failure, timeout, etc.)  
**When** processing a user query  
**Then** the system shall:
- Display a user-friendly error message
- Suggest alternative actions or retry
- Log error details for debugging
- Not expose technical stack traces to users
- Maintain conversation context after error
- Recover gracefully without requiring page refresh

**And** critical errors shall trigger alerts to the operations team

---

## 8. Out of Scope (v1)

The following features are explicitly excluded from the initial release:

### Not Included in v1
- âŒ **Real Patient Data Processing**: No EHR integration or patient-level data analysis
- âŒ **Predictive Analytics**: No AI-driven predictions of clinical outcomes or drug efficacy
- âŒ **Medical Diagnosis Support**: No diagnostic decision support tools
- âŒ **Treatment Recommendations**: No personalized treatment suggestions
- âŒ **Prescription Writing**: No e-prescribing or medication ordering
- âŒ **Image Analysis**: No medical imaging or pathology slide analysis
- âŒ **Genomic Data Analysis**: No DNA/RNA sequence analysis or variant interpretation
- âŒ **Real-Time Clinical Decision Support**: No integration with clinical workflows
- âŒ **Multi-User Collaboration**: No real-time co-editing or team workspaces
- âŒ **Mobile Native Apps**: Web-responsive only; no iOS/Android apps
- âŒ **Offline Mode**: Requires internet connection
- âŒ **Custom Data Upload**: No user-uploaded proprietary datasets
- âŒ **API Access for Third Parties**: No public API for external integrations
- âŒ **Advanced Visualizations**: No interactive charts or 3D molecular structures
- âŒ **Multilingual Support**: English only
- âŒ **Voice Interface**: No speech-to-text or text-to-speech
- âŒ **Integration with Lab Systems**: No LIMS or laboratory data integration
- âŒ **Automated Literature Monitoring**: No alerts for new publications (future feature)
- âŒ **Meta-Analysis Tools**: No statistical meta-analysis capabilities
- âŒ **Grant Writing Assistance**: No NIH grant proposal generation
- âŒ **Patent Search**: No patent database integration

### Future Considerations (Post-v1)
- ðŸ“… **Collaborative Workspaces**: Team sharing and annotation features
- ðŸ“… **Advanced Analytics**: Statistical analysis and meta-analysis tools
- ðŸ“… **Automated Alerts**: Notifications for new relevant publications
- ðŸ“… **API Access**: Developer API for institutional integrations
- ðŸ“… **Mobile Apps**: Native iOS and Android applications
- ðŸ“… **Multilingual Support**: Support for Spanish, Mandarin, German
- ðŸ“… **Custom Data Sources**: Secure upload of proprietary research data
- ðŸ“… **Enhanced Visualizations**: Interactive charts, forest plots, network diagrams
- ðŸ“… **Integration Ecosystem**: Plugins for Zotero, Mendeley, EndNote

---

## Appendix

### A. Glossary

| Term | Definition |
|------|------------|
| **RAG** | Retrieval-Augmented Generation: AI technique combining information retrieval with text generation |
| **PMID** | PubMed Identifier: Unique identifier for articles in PubMed database |
| **NCT Number** | National Clinical Trial number: Unique identifier for trials in ClinicalTrials.gov |
| **FDA** | Food and Drug Administration: US regulatory agency for drugs and medical devices |
| **EMA** | European Medicines Agency: EU regulatory agency for medicines |
| **ICH** | International Council for Harmonisation: Standards for pharmaceutical development |
| **HIPAA** | Health Insurance Portability and Accountability Act: US healthcare privacy law |
| **PHI** | Protected Health Information: Individually identifiable health data |
| **PII** | Personally Identifiable Information: Data that can identify an individual |
| **WCAG** | Web Content Accessibility Guidelines: Accessibility standards for web content |
| **SLA** | Service Level Agreement: Commitment to service availability and performance |

### B. Reference Documents
- FDA Guidance Documents: https://www.fda.gov/regulatory-information/search-fda-guidance-documents
- ClinicalTrials.gov API: https://clinicaltrials.gov/api/
- PubMed API (E-utilities): https://www.ncbi.nlm.nih.gov/books/NBK25501/
- WCAG 2.1 Guidelines: https://www.w3.org/WAI/WCAG21/quickref/
- HIPAA Privacy Rule: https://www.hhs.gov/hipaa/for-professionals/privacy/index.html

### C. Revision History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2026-02-13 | Product Team | Initial requirements document for hackathon submission |

---

**Document Status**: Draft for Hackathon Submission  
**Last Updated**: February 13, 2026  
**Next Review**: Post-Hackathon Feedback Incorporation
